Dynavax Technologies
DVAX
#5048
Rank
ยฃ1.35 B
Marketcap
ยฃ11.58
Share price
0.00%
Change (1 day)
8.70%
Change (1 year)

EPS for Dynavax Technologies (DVAX)

EPS in 2023 (TTM): ยฃ0.76

According to Dynavax Technologies 's latest financial reports the company's current EPS (TTM) is -ยฃ0.24. In 2022 the company made an earnings per share (EPS) of ยฃ1.73 an increase over its 2021 EPS that were of ยฃ0.46.

EPS history for Dynavax Technologies from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.76-56.12%
2022ยฃ1.73278.69%
2021ยฃ0.46-178.21%
2020-ยฃ0.58-64.71%
2019-ยฃ1.65-13.33%
2018-ยฃ1.9038.59%
2017-ยฃ1.37-36.77%
2016-ยฃ2.17-11.55%
2015-ยฃ2.46-4.64%
2014-ยฃ2.58-9.92%
2013-ยฃ2.86-6.59%
2012-ยฃ3.065.13%
2011-ยฃ2.91-43.48%
2010-ยฃ5.15-9.21%
2009-ยฃ5.6846.15%
2008-ยฃ3.88-65.56%
2007-ยฃ11.28-6.21%
2006-ยฃ12.03106.41%
2005-ยฃ5.83-8.24%
2004-ยฃ6.35-91.53%
2003-ยฃ74.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.57-337.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ12.12-5,168.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.76-837.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.32 868.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.74-410.22%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ4.99-2,187.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.15-999.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ1.51-731.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-296.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel